Age 0 3 0 3 B-age
greater 4 11 4 11 O
than 12 16 12 16 O
or 17 19 17 19 O
equal 20 25 20 25 O
to18 26 30 26 30 O
years 31 36 31 36 I-lower_bound

Any 0 3 37 40 O
uncontrolled 4 16 41 53 B-chronic_disease
medical 17 24 54 61 I-chronic_disease
illness 25 32 62 69 I-chronic_disease
that 33 37 70 74 O
precludes 38 47 75 84 O
the 48 51 85 88 O
patient 52 59 89 96 O
from 60 64 97 101 O
undergoing 65 75 102 112 O
a 76 77 113 114 O
biopsy 78 84 115 121 B-treatment
for 85 88 122 125 I-treatment
molecular 89 98 126 135 I-treatment
profiling 99 108 136 145 I-treatment
and 109 112 146 149 O
/ 113 114 150 151 O
or 115 117 152 154 O
receiving 118 127 155 164 O
treatment 128 137 165 174 B-treatment
under 138 143 175 180 I-treatment
one 144 147 181 184 I-treatment
of 148 150 185 187 I-treatment
the 151 154 188 191 I-treatment
experimental 155 167 192 204 I-treatment
arms 168 172 205 209 I-treatment
of 173 175 210 212 I-treatment
the 176 179 213 216 I-treatment
study 180 185 217 222 I-treatment

Cardiac 0 7 223 230 B-chronic_disease
arrhythmia 8 18 231 241 I-chronic_disease

Individuals 0 11 242 253 O
who 12 15 254 257 O
meet 16 20 258 262 O
the 21 24 263 266 O
eligibility 25 36 267 278 O
criteria 37 45 279 287 O
for 46 49 288 291 O
EGFR 50 54 292 296 B-clinical_variable
germline 55 63 297 305 O
mutation 64 72 306 314 O
testing 73 80 315 322 O
but 81 84 323 326 O
who 85 88 327 330 O
do 89 91 331 333 O
not 92 95 334 337 O
have 96 100 338 342 O
advanced 101 109 343 351 O
cancer 110 116 352 358 O
as 117 119 359 361 O
defined 120 127 362 369 O
in 128 130 370 372 O
3.1.1 131 136 373 378 O
may 137 140 379 382 O
enroll 141 147 383 389 O
for 148 151 390 393 O
EGFR 152 156 394 398 O
germline 157 165 399 407 O
mutation 166 174 408 416 O
testing 175 182 417 424 O
only 183 187 425 429 O
and 188 191 430 433 O
will 192 196 434 438 O
not 197 200 439 442 O
be 201 203 443 445 O
eligible 204 212 446 454 O
for 213 216 455 458 O
the 217 220 459 462 O
treatment 221 230 463 472 B-treatment
or 231 233 473 475 O
NOS 234 237 476 479 O
arms 238 242 480 484 O

Ongoing 0 7 485 492 O
or 8 10 493 495 O
uncontrolled 11 23 496 508 O
, 23 24 508 509 O
symptomatic 25 36 510 521 O
congestive 37 47 522 532 B-chronic_disease
heart 48 53 533 538 I-chronic_disease
failure 54 61 539 546 I-chronic_disease
( 62 63 547 548 O
Class 63 68 548 553 O
III 69 72 554 557 O
or 73 75 558 560 O
IV 76 78 561 563 O
as 79 81 564 566 O
defined 82 89 567 574 O
by 90 92 575 577 O
the 93 96 578 581 O
NYHA 97 101 582 586 O
functional 102 112 587 597 O
classification 113 127 598 612 O
system 128 134 613 619 O

Patients 0 8 620 628 O
may 9 12 629 632 O
not 13 16 633 636 O
be 17 19 637 639 O
receiving 20 29 640 649 O
any 30 33 650 653 O
other 34 39 654 659 O
investigational 40 55 660 675 B-treatment
agents 56 62 676 682 I-treatment
or 63 65 683 685 O
other 66 71 686 691 O
medications 72 83 692 703 O
for 84 87 704 707 O
the 88 91 708 711 O
treatment 92 101 712 721 O
of 102 104 722 724 O
their 105 110 725 730 O
malignancy 111 121 731 741 B-cancer

Patients 0 8 742 750 O
must 9 13 751 755 O
have 14 18 756 760 O
biopsiable 19 29 761 771 B-chronic_disease
disease 30 37 772 779 I-chronic_disease
and 38 41 780 783 O
be 42 44 784 786 O
willing 45 52 787 794 O
to 53 55 795 797 O
undergo 56 63 798 805 O
biopsy 64 70 806 812 B-treatment
for 71 74 813 816 O
molecular 75 84 817 826 B-treatment
profiling 85 94 827 836 I-treatment

Patients 0 8 837 845 O
must 9 13 846 850 O
have 14 18 851 855 O
enough 19 25 856 862 O
and 26 29 863 866 O
adequate 30 38 867 875 O
archival 39 47 876 884 O
material 48 56 885 893 O
from 57 61 894 898 O
a 62 63 899 900 O
previous 64 72 901 909 B-treatment
biopsy 73 79 910 916 I-treatment
to 80 82 917 919 I-treatment
perform 83 90 920 927 I-treatment
molecular 91 100 928 937 I-treatment
profiling 101 110 938 947 I-treatment
analyses 111 119 948 956 I-treatment
. 119 120 956 957 O
The 121 124 958 961 O
adequacy 125 133 962 970 O
of 134 136 971 973 O
the 137 140 974 977 O
material 141 149 978 986 O
provided 150 158 987 995 O
will 159 163 996 1000 O
be 164 166 1001 1003 O
determined 167 177 1004 1014 O
by 178 180 1015 1017 O
the 181 184 1018 1021 O
principal 185 194 1022 1031 O
investigator 195 207 1032 1044 O
in 208 210 1045 1047 O
conjunction 211 222 1048 1059 O
with 223 227 1060 1064 O
the 228 231 1065 1068 O
laboratories 232 244 1069 1081 O
performing 245 255 1082 1092 O
the 256 259 1093 1096 O
molecular 260 269 1097 1106 O
profiling 270 279 1107 1116 O
analyses 280 288 1117 1125 O

Patients 0 8 1126 1134 O
must 9 13 1135 1139 O
have 14 18 1140 1144 O
previously 19 29 1145 1155 O
undergone 30 39 1156 1165 O
a 40 41 1166 1167 O
successful 42 52 1168 1178 O
molecular 53 62 1179 1188 B-treatment
profiling 63 72 1189 1198 I-treatment
of 73 75 1199 1201 O
their 76 81 1202 1207 O
tumor 82 87 1208 1213 B-cancer
with 88 92 1214 1218 O
mutation 93 101 1219 1227 O
analysis 102 110 1228 1236 O
of 111 113 1237 1239 O
the 114 117 1240 1243 O
genes 118 123 1244 1249 O
described 124 133 1250 1259 O
in 134 136 1260 1262 O
section 137 144 1263 1270 O
5.2 145 148 1271 1274 O
, 148 149 1274 1275 O
as 150 152 1276 1278 O
part 153 157 1279 1283 O
of 158 160 1284 1286 O
this 161 165 1287 1291 O
protocol 166 174 1292 1300 O
( 175 176 1301 1302 O
crossover 176 185 1302 1311 O
patients 186 194 1312 1320 O
) 194 195 1320 1321 O
or 196 198 1322 1324 O
other 199 204 1325 1330 O
molecular 205 214 1331 1340 O
profiling 215 224 1341 1350 O
protocols 225 234 1351 1360 O
such 235 239 1361 1365 O
as 240 242 1366 1368 O
the 243 246 1369 1372 O
Lung 247 251 1373 1377 O
Cancer 252 258 1378 1384 O
Mutation 259 267 1385 1393 O
Consortium 268 278 1394 1404 O
protocol 279 287 1405 1413 O
among 288 293 1414 1419 O
others 294 300 1420 1426 O

Patients 0 8 1427 1435 O
who 9 12 1436 1439 O
have 13 17 1440 1444 O
had 18 21 1445 1448 O
major 22 27 1449 1454 B-treatment
surgery 28 35 1455 1462 I-treatment
, 35 36 1462 1463 O
chemotherapy 37 49 1464 1476 B-treatment
or 50 52 1477 1479 O
radiotherapy 53 65 1480 1492 B-treatment
within 66 72 1493 1499 O
2 73 74 1500 1501 B-upper_bound
weeks 75 80 1502 1507 I-upper_bound
prior 81 86 1508 1513 I-upper_bound
to 87 89 1514 1516 O
entering 90 98 1517 1525 O
the 99 102 1526 1529 O
study 103 108 1530 1535 O
or 109 111 1536 1538 O
those 112 117 1539 1544 O
who 118 121 1545 1548 O
have 122 126 1549 1553 O
not 127 130 1554 1557 O
recovered 131 140 1558 1567 O
from 141 145 1568 1572 O
adverse 146 153 1573 1580 O
events 154 160 1581 1587 O
due 161 164 1588 1591 O
to 165 167 1592 1594 O
agents 168 174 1595 1601 O
administered 175 187 1602 1614 O
more 188 192 1615 1619 O
than 193 197 1620 1624 O
2 198 199 1625 1626 O
weeks 200 205 1627 1632 O
earlier 206 213 1633 1640 O

Patients 0 8 1641 1649 O
with 9 13 1650 1654 O
QTc 14 17 1655 1658 B-clinical_variable
prolongation 18 30 1659 1671 O
( 31 32 1672 1673 O
defined 32 39 1673 1680 O
as 40 42 1681 1683 O
a 43 44 1684 1685 O
QTc 45 48 1686 1689 B-clinical_variable
interval 49 57 1690 1698 I-clinical_variable
equal 58 63 1699 1704 O
to 64 66 1705 1707 O
or 67 69 1708 1710 O
greater 70 77 1711 1718 O
than 78 82 1719 1723 O
500 83 86 1724 1727 B-lower_bound
msec 87 91 1728 1732 I-lower_bound
) 91 92 1732 1733 O
or 93 95 1734 1736 O
other 96 101 1737 1742 O
significant 102 113 1743 1754 O
ECG 114 117 1755 1758 B-clinical_variable
abnormalities 118 131 1759 1772 O

Patients 0 8 1773 1781 O
with 9 13 1782 1786 O
any 14 17 1787 1790 O
condition 18 27 1791 1800 O
( 28 29 1801 1802 O
e.g. 29 33 1802 1806 O
, 33 34 1806 1807 O
gastrointestinal 35 51 1808 1824 B-chronic_disease
tract 52 57 1825 1830 I-chronic_disease
disease 58 65 1831 1838 I-chronic_disease
resulting 66 75 1839 1848 O
in 76 78 1849 1851 O
an 79 81 1852 1854 O
inability 82 91 1855 1864 O
to 92 94 1865 1867 O
take 95 99 1868 1872 O
oral 100 104 1873 1877 B-treatment
medication 105 115 1878 1888 I-treatment
or 116 118 1889 1891 O
a 119 120 1892 1893 O
requirement 121 132 1894 1905 O
for 133 136 1906 1909 O
IV 137 139 1910 1912 B-treatment
alimentation 140 152 1913 1925 I-treatment
, 152 153 1925 1926 O
prior 154 159 1927 1932 B-treatment
surgical 160 168 1933 1941 I-treatment
procedures 169 179 1942 1952 I-treatment
affecting 180 189 1953 1962 O
absorption 190 200 1963 1973 O
, 200 201 1973 1974 O
or 202 204 1975 1977 O
active 205 211 1978 1984 B-chronic_disease
peptic 212 218 1985 1991 I-chronic_disease
ulcer 219 224 1992 1997 I-chronic_disease
disease 225 232 1998 2005 I-chronic_disease
) 232 233 2005 2006 O
that 234 238 2007 2011 O
impairs 239 246 2012 2019 O
their 247 252 2020 2025 O
ability 253 260 2026 2033 O
to 261 263 2034 2036 O
swallow 264 271 2037 2044 O
and 272 275 2045 2048 O
retain 276 282 2049 2055 O
tablets 283 290 2056 2063 O

Patients 0 8 2064 2072 O
with 9 13 2073 2077 O
histologically 14 28 2078 2092 O
confirmed 29 38 2093 2102 O
advanced 39 47 2103 2111 O
NSCLC 48 53 2112 2117 B-cancer
, 53 54 2117 2118 O
SCLC 55 59 2119 2123 O
and 60 63 2124 2127 O
thymic 64 70 2128 2134 B-cancer
malignancies 71 83 2135 2147 I-cancer
for 84 87 2148 2151 O
whom 88 92 2152 2156 O
surgical 93 101 2157 2165 B-treatment
resection 102 111 2166 2175 I-treatment
or 112 114 2176 2178 O
multimodality 115 128 2179 2192 B-treatment
therapy 129 136 2193 2200 I-treatment
with 137 141 2201 2205 O
curative 142 150 2206 2214 O
intent 151 157 2215 2221 O
is 158 160 2222 2224 O
not 161 164 2225 2228 O
feasible 165 173 2229 2237 O
. 173 174 2237 2238 O
For 175 178 2239 2242 O
patients 179 187 2243 2251 O
with 188 192 2252 2256 O
Stage 193 198 2257 2262 B-cancer
III 199 202 2263 2266 I-cancer
NSCLC 203 208 2267 2272 I-cancer
, 208 209 2272 2273 O
who 210 213 2274 2277 O
can 214 217 2278 2281 O
be 218 220 2282 2284 O
encompassed 221 232 2285 2296 O
by 233 235 2297 2299 O
a 236 237 2300 2301 O
radiation 238 247 2302 2311 B-treatment
port 248 252 2312 2316 I-treatment
, 252 253 2316 2317 O
definitive 254 264 2318 2328 O
XRT 265 268 2329 2332 B-treatment
should 269 275 2333 2339 O
have 276 280 2340 2344 O
been 281 285 2345 2349 O
performed 286 295 2350 2359 O
first 296 301 2360 2365 O
when 302 306 2366 2370 O
possible 307 315 2371 2379 O

Patients 0 8 2380 2388 O
with 9 13 2389 2393 O
symptomatic 14 25 2394 2405 B-cancer
brain 26 31 2406 2411 I-cancer
metastases 32 42 2412 2422 I-cancer
should 43 49 2423 2429 O
be 50 52 2430 2432 O
excluded 53 61 2433 2441 O
from 62 66 2442 2446 O
this 67 71 2447 2451 O
clinical 72 80 2452 2460 O
trial 81 86 2461 2466 O
because 87 94 2467 2474 O
of 95 97 2475 2477 O
their 98 103 2478 2483 O
poor 104 108 2484 2488 O
prognosis 109 118 2489 2498 B-chronic_disease
and 119 122 2499 2502 O
because 123 130 2503 2510 O
they 131 135 2511 2515 O
often 136 141 2516 2521 O
develop 142 149 2522 2529 O
progressive 150 161 2530 2541 O
neurologic 162 172 2542 2552 B-chronic_disease
dysfunction 173 184 2553 2564 I-chronic_disease
that 185 189 2565 2569 O
would 190 195 2570 2575 O
confound 196 204 2576 2584 O
the 205 208 2585 2588 O
evaluation 209 219 2589 2599 O
of 220 222 2600 2602 O
neurologic 223 233 2603 2613 O
and 234 237 2614 2617 O
other 238 243 2618 2623 O
adverse 244 251 2624 2631 O
events 252 258 2632 2638 O
. 258 259 2638 2639 O
However 260 267 2640 2647 O
, 267 268 2647 2648 O
patients 269 277 2649 2657 O
who 278 281 2658 2661 O
have 282 286 2662 2666 O
had 287 290 2667 2670 O
treatment 291 300 2671 2680 B-treatment
for 301 304 2681 2684 O
their 305 310 2685 2690 O
brain 311 316 2691 2696 O
metastases 317 327 2697 2707 O
and 328 331 2708 2711 O
whose 332 337 2712 2717 O
brain 338 343 2718 2723 B-cancer
metastatic 344 354 2724 2734 I-cancer
disease 355 362 2735 2742 I-cancer
status 363 369 2743 2749 O
has 370 373 2750 2753 O
remained 374 382 2754 2762 O
stable 383 389 2763 2769 O
for 390 393 2770 2773 O
at 394 396 2774 2776 O
least 397 402 2777 2782 O
1 403 404 2783 2784 B-lower_bound
week 405 409 2785 2789 I-lower_bound
after 410 415 2790 2795 O
the 416 419 2796 2799 O
end 420 423 2800 2803 O
of 424 426 2804 2806 O
brain 427 432 2807 2812 B-treatment
radiation 433 442 2813 2822 I-treatment
may 443 446 2823 2826 O
be 447 449 2827 2829 O
enrolled 450 458 2830 2838 O
to 459 461 2839 2841 O
undergo 462 469 2842 2849 O
molecular 470 479 2850 2859 O
profiling 480 489 2860 2869 O
at 490 492 2870 2872 O
the 493 496 2873 2876 O
discretion 497 507 2877 2887 O
of 508 510 2888 2890 O
the 511 514 2891 2894 O
principal 515 524 2895 2904 O
investigator 525 537 2905 2917 O
. 537 538 2917 2918 O
In 539 541 2919 2921 O
addition 542 550 2922 2930 O
, 550 551 2930 2931 O
brain 552 557 2932 2937 O
metastatic 558 568 2938 2948 O
disease 569 576 2949 2956 O
should 577 583 2957 2963 O
be 584 586 2964 2966 O
stable 587 593 2967 2973 O
for 594 597 2974 2977 O
at 598 600 2978 2980 O
least 601 606 2981 2986 O
4 607 608 2987 2988 B-lower_bound
weeks 609 614 2989 2994 I-lower_bound
, 614 615 2994 2995 O
before 616 622 2996 3002 O
the 623 626 3003 3006 O
patients 627 635 3007 3015 O
can 636 639 3016 3019 O
be 640 642 3020 3022 O
enrolled 643 651 3023 3031 O
in 652 654 3032 3034 O
any 655 658 3035 3038 O
of 659 661 3039 3041 O
the 662 665 3042 3045 O
experimental 666 678 3046 3058 O
treatment 679 688 3059 3068 O
arms 689 693 3069 3073 O

Patients 0 8 3074 3082 O
with 9 13 3083 3087 O
tumor 14 19 3088 3093 B-cancer
amenable 20 28 3094 3102 O
to 29 31 3103 3105 O
potentially 32 43 3106 3117 B-treatment
curative 44 52 3118 3126 I-treatment
therapy 53 60 3127 3134 I-treatment

The 0 3 3135 3138 O
eligibility 4 15 3139 3150 O
of 16 18 3151 3153 O
patients 19 27 3154 3162 O
taking 28 34 3163 3169 O
medications 35 46 3170 3181 B-treatment
that 47 51 3182 3186 O
are 52 55 3187 3190 O
potent 56 62 3191 3197 B-treatment
inducers 63 71 3198 3206 I-treatment
or 72 74 3207 3209 I-treatment
inhibitors 75 85 3210 3220 I-treatment
of 86 88 3221 3223 O
that 89 93 3224 3228 O
enzyme 94 100 3229 3235 O
will 101 105 3236 3240 O
be 106 108 3241 3243 O
determined 109 119 3244 3254 O
following 120 129 3255 3264 O
a 130 131 3265 3266 O
review 132 138 3267 3273 O
of 139 141 3274 3276 O
their 142 147 3277 3282 O
case 148 152 3283 3287 O
by 153 155 3288 3290 O
the 156 159 3291 3294 O
Principal 160 169 3295 3304 O
Investigator 170 182 3305 3317 O
. 182 183 3317 3318 O
( 184 185 3319 3320 O
A 185 186 3320 3321 O
list 187 191 3322 3326 O
of 192 194 3327 3329 O
potent 195 201 3330 3336 O
CYP3A4 202 208 3337 3343 B-treatment
inducers 209 217 3344 3352 I-treatment
or 218 220 3353 3355 I-treatment
inhibitors 221 231 3356 3366 I-treatment
can 232 235 3367 3370 O
be 236 238 3371 3373 O
found 239 244 3374 3379 O
in 245 247 3380 3382 O
Appendix 248 256 3383 3391 O
F 257 258 3392 3393 O
) 258 259 3393 3394 O
. 259 260 3394 3395 O
Every 261 266 3396 3401 O
effort 267 273 3402 3408 O
should 274 280 3409 3415 O
be 281 283 3416 3418 O
made 284 288 3419 3423 O
to 289 291 3424 3426 O
switch 292 298 3427 3433 O
patients 299 307 3434 3442 O
taking 308 314 3443 3449 O
such 315 319 3450 3454 O
agents 320 326 3455 3461 O
or 327 329 3462 3464 O
substances 330 340 3465 3475 O
to 341 343 3476 3478 O
other 344 349 3479 3484 O
medications 350 361 3485 3496 O
before 362 368 3497 3503 O
they 369 373 3504 3508 O
begin 374 379 3509 3514 O
treatment 380 389 3515 3524 B-treatment
with 390 394 3525 3529 I-treatment
one 395 398 3530 3533 I-treatment
of 399 401 3534 3536 I-treatment
the 402 405 3537 3540 I-treatment
experimental 406 418 3541 3553 I-treatment
drug 419 423 3554 3558 I-treatment
included 424 432 3559 3567 O
in 433 435 3568 3570 O
this 436 440 3571 3575 O
protocol 441 449 3576 3584 O
, 449 450 3584 3585 O
particularly 451 463 3586 3598 O
patients 464 472 3599 3607 O
with 473 477 3608 3612 O
gliomas 478 485 3613 3620 B-cancer
or 486 488 3621 3623 I-cancer
brain 489 494 3624 3629 I-cancer
metastases 495 505 3630 3640 I-cancer
who 506 509 3641 3644 O
are 510 513 3645 3648 O
taking 514 520 3649 3655 O
enzyme 521 527 3656 3662 B-treatment
- 527 528 3662 3663 I-treatment
inducing 528 536 3663 3671 I-treatment
anticonvulsant 537 551 3672 3686 I-treatment
agents 552 558 3687 3693 I-treatment
. 558 559 3693 3694 O
A 560 561 3695 3696 O
comprehensive 562 575 3697 3710 O
list 576 580 3711 3715 O
of 581 583 3716 3718 O
medications 584 595 3719 3730 O
and 596 599 3731 3734 O
substances 600 610 3735 3745 O
known 611 616 3746 3751 O
or 617 619 3752 3754 O
with 620 624 3755 3759 O
the 625 628 3760 3763 O
potential 629 638 3764 3773 O
to 639 641 3774 3776 O
alter 642 647 3777 3782 O
the 648 651 3783 3786 O
pharmacokinetics 652 668 3787 3803 O
of 669 671 3804 3806 O
sunitinib 672 681 3807 3816 B-treatment
through 682 689 3817 3824 O
CYP3A4 690 696 3825 3831 O

Uncontrolled 0 12 3832 3844 B-chronic_disease
diabetes 13 21 3845 3853 I-chronic_disease

Uncontrolled 0 12 3854 3866 O
hypertension 13 25 3867 3879 B-chronic_disease

Uncontrolled 0 12 3880 3892 O
psychiatric 13 24 3893 3904 B-chronic_disease
illness 25 32 3905 3912 I-chronic_disease
/ 32 33 3912 3913 O
social 33 39 3913 3919 B-chronic_disease
situations 40 50 3920 3930 I-chronic_disease
that 51 55 3931 3935 O
would 56 61 3936 3941 O
limit 62 67 3942 3947 O
compliance 68 78 3948 3958 O
with 79 83 3959 3963 O
study 84 89 3964 3969 O
requirements 90 102 3970 3982 O

Unstable 0 8 3983 3991 B-chronic_disease
angina 9 15 3992 3998 I-chronic_disease
pectoris 16 24 3999 4007 I-chronic_disease

